Ketamine Asthma Acute trial NCT07728851 (Phase 2)
Phase 2 trial NCT07728851 tests nebulized ketamine in children with acute asthma; BioQ adds ChEMBL potency data and 682 registered ketamine trials.
BioQ Blog
Every BioQ post about pChEMBL: real search results, sources and the query to repeat it.
Phase 2 trial NCT07728851 tests nebulized ketamine in children with acute asthma; BioQ adds ChEMBL potency data and 682 registered ketamine trials.
Script a gene-to-drug lookup with the BioQ REST API: one call for TP53 returns 18 drugs with stage and pChEMBL potency, data as of 2026-11-06.
A new phase 2 trial, NCT07582159, adds acalabrutinib to tafasitamab and venetoclax in CLL/SLL; BioQ shows its BTK potency and 121 registered trials.